TMC353121 has significant antiviral activity in a wide dose
range in BALB/c mice
The antiviral efficacy of TMC353121 was explored in a wide
dose range in prophylactic regimens with the drug administered
as a single dose; 60 min prior to RSV challenge (studies 3
and 4; table 2).